Does the ‘equal management of equal risks’ model cause overtreatment in patients with positive cervical cytology results for ASCUS/non‐HPV16/18 oncogenic types?
Diagnostic Cytopathology2018Vol. 47(2), pp. 105–109
Citations Over Time
İbrahim Karaca, Mustafa Öztürk, Cihan Comba, Gökhan Demirayak, Şakir Volkan Erdoğan, Murat Hoşgören, İsa Aykut Özdemir
Abstract
This study believes that the ASCCP recommendations, which state that a 'colposcopy should be performed on all women with positive cytology for ASCUS/non-HPV16/18 oncogenic types', is required to be revised. This will reduce the rate of the colposcopy procedures by 40% in women with ASCUS/HPV positivity.
Related Papers
- → Atypical squamous cells of undetermined significance(2001)9 cited
- → Hybrid Capture Human Papillomavirus Testing As an Adjunct to the Follow-Up of Patients With ASCUS and LGSIL Pap Smears: A Study of a Screening Population(2000)
- Explore the value of the further method in ASCUS of cervical smear(2008)
- Application of the High-risk HPV Testing and Colposcopy in Diagnosing Atypical Squamous Cells of Undetermined Significance(2012)
- Clinical Analysis of ASCUS via Human Papillomavirus Detection(2014)